Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intra-Cellular Ther
(NQ:
ITCI
)
65.41
+2.20 (+3.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
844,160
Open
63.11
Bid (Size)
63.37 (1)
Ask (Size)
66.95 (1)
Prev. Close
63.21
Today's Range
62.58 - 65.60
52wk Range
42.01 - 66.56
Shares Outstanding
94,324,313
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Analyst Expectations for Intra-Cellular Therapies's Future
June 05, 2023
Via
Benzinga
Recap: Intra-Cellular Therapies Q1 Earnings
May 04, 2023
Via
Benzinga
Performance
YTD
+26.62%
+26.62%
1 Month
+2.12%
+2.12%
3 Month
+37.44%
+37.44%
6 Month
+20.57%
+20.57%
1 Year
+12.39%
+12.39%
More News
Read More
A Preview Of Intra-Cellular Therapies's Earnings
May 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
April 20, 2023
Via
Benzinga
Analyst Ratings for Intra-Cellular Therapies
March 29, 2023
Via
Benzinga
Intra-Cellular Stock Surges As Antipsychotic Shows Benefit In Depression Patients With Mixed Features
March 28, 2023
Via
Benzinga
Analyst Ratings for Intra-Cellular Therapies
March 02, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
Via
Benzinga
Airbnb To Rally Around 59%? Here Are 10 Other Analyst Forecasts For Wednesday
March 29, 2023
Via
Benzinga
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 28, 2023
Via
Benzinga
Earnings Outlook For Intra-Cellular Therapies
February 28, 2023
Via
Benzinga
Looking Into Intra-Cellular Therapies's Return On Capital Employed
November 23, 2022
Via
Benzinga
Where Intra-Cellular Therapies Stands With Analysts
August 11, 2022
Via
Benzinga
Why Intra-Cellular Therapies Climbed Tuesday
March 28, 2023
Via
The Motley Fool
Intra-Cellular's Big Depression Drug Market Just Got Bigger — And Shares Catapulted
March 28, 2023
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 28, 2023
Via
Benzinga
Biotech Sector Working Fast to Combat Alzheimer’s Disease Cases That are Set to Explode
March 15, 2023
Via
FinancialNewsMedia
Exposures
COVID-19
Recap: Intra-Cellular Therapies Q3 Earnings
November 03, 2022
Via
Benzinga
Intra-Cellular Therapies's Earnings: A Preview
November 02, 2022
Via
Benzinga
Looking Into Intra-Cellular Therapies's Return On Capital Employed
September 02, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022
August 22, 2022
Via
Benzinga
Illumina, Poshmark, Olo And Some Other Big Losers From Friday
August 15, 2022
Via
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Via
Benzinga
Intra-Cellular Therapies: Q2 Earnings Insights
August 09, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.